Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01886105 · ClinicalTrials.gov registry record · Phase 2
Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma
A Phase 2 study, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- Terminated
- Registry status
- Phase 2
- Development phase
- 4
- Enrollment target
NCT01886105 is a Phase 2 study that was terminated before completion, run by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. The registered enrollment target is 4 participants.
The verdict
NCT01886105, a Phase 2 study, was terminated before completion, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 4 participants
- Enrollment target
Study Summary
The primary goal of this study will be to examine tumor response after radiation treatment via a combination of Samarium-153 EDTMP and external beam radiotherapy.
Interventions
- RADIATION External Beam Radiotherapy
- DRUG Sm-EDTMP
- OTHER Autologous Stem Cell Infusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2013-08-19 |
| Est. Completion | 2017-06-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01886105
The ClinicalTrials.gov registry entry for NCT01886105 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which External Beam Radiotherapy is the first listed.
NCT01886105 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01886105 about?
NCT01886105 is a clinical study titled "Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma". The primary goal of this study will be to examine tumor response after radiation treatment via a combination of Samarium-153 EDTMP and external beam radiotherapy.
What is the current status of trial NCT01886105?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 4 participants. The study started on 2013-08-19. Estimated completion is 2017-06-11.
What interventions are being tested in trial NCT01886105?
The interventions under investigation include: External Beam Radiotherapy (RADIATION), Sm-EDTMP (DRUG), Autologous Stem Cell Infusion (OTHER).
Who is sponsoring clinical trial NCT01886105?
This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.